Clinical Trials on Pancreatic Transplantation

Total 8531 results

Novartis Pharmaceuticals

Completed

Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Withdrawn

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients (HERMES)

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Kidney Transplantation

United States
Novartis

Completed

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

Kidney Transplantation

United States
Novartis Pharmaceuticals

Completed

Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen

Kidney Transplantation

Germany, Switzerland
National Institute of Allergy and Infectious Diseases...

Terminated

A Study To Test An Anti-Rejection Therapy After Kidney Transplantation

Kidney Transplantation

United States
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN); Clinical Trials in Organ Transplantation

Completed

Associating Renal Transplantation With the ITN Signature of Tolerance (ARTIST)

Kidney Transplantation

United States
Novartis Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients (AEB071)

Kidney Transplantation

Germany, Switzerland, Singapore, Colombia, Argentina, Slovakia, Australia, Austria, Belgium, Brazil, Czech Republic, France, Italy, Netherlands, Norway, Spain, Taiwan
Novartis Pharmaceuticals

Completed

Renal Safety of Everolimus in Addition to Cyclosporine Microemulsion in Cardiac Transplant Recipients.

Cardiac Transplantation
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation

Kidney Transplantation
Oslo University Hospital
Norwegian Health Association

Completed

Imminently Effect of Interval Training With High Intensity (HIT) After Heart Transplantation

Heart Transplantation

Norway
Hoffmann-La Roche

Completed

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

Kidney Transplantation

Belgium, Spain, Sweden, Germany, United States, France, Canada, United Kingdom, Australia, Poland, Norway, Mexico
National Heart, Lung, and Blood Institute (NHLBI)
University of Pittsburgh

Terminated

Thymic Tolerance in Pediatric Heart Transplantation

Heart Transplantation

United States
Hoffmann-La Roche

Completed

A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation

Heart Transplantation

United States, Canada, Germany, Sweden
University of Utah

Completed

Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

Kidney Transplantation

United States
Novartis Pharmaceuticals

Completed

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients (SIMCER)

Liver Transplantation

France
National Institute of Allergy and Infectious Diseases...

Completed

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

Cardiac Transplantation

United States
Astellas Pharma Inc

Completed

A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients

Liver Transplantation

China
Emory University

Terminated

Properties of Mesenchymal Stem Cells in Lung Transplant

Lung Transplantation

United States
University of Cincinnati
Astellas Pharma Inc

Completed

Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients

Liver Transplantation

United States
University of Sao Paulo General Hospital

Unknown

Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

Kidney Transplantation

Brazil
Stanford University

Unknown

Do Technology Apps Improve Compliance in Adolescent Renal Transplant Recipients?

Kidney Transplantation

United States
Hoffmann-La Roche

Completed

A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients

Kidney Transplantation

Germany
Chong Kun Dang Pharmaceutical

Completed

Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients (My-Rept_KT_P4)

Kidney Transplantation

Korea, Republic of
Mansoura University

Completed

Validity of Different Prognostic Models Assessing 1 Year Survival After Liver Transplantation (ProgModels)

Liver Transplantation
International Institute of Rescue Research and...

Unknown

Attitudes About Organ Transplantation (KAPsurvey)

Transplantation, Organ

Poland
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Completed

Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

Kidney Transplantation

Canada, United States
Astellas Pharma Inc

Completed

Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation (DISTAMP)

Kidney Transplantation

Poland, Czech Republic, Hungary, Slovakia
Astellas Pharma Inc

Completed

To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation. (RESTORE)

Kidney Transplantation

Belgium, France, Germany, Spain, Australia, Italy, Austria, Romania, United Kingdom, Poland, Hungary, Sweden, Netherlands, Czech Republic
Novartis Pharmaceuticals

Terminated

Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

Renal Transplantation

Germany
Hoffmann-La Roche

Completed

A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.

Kidney Transplantation

China
Aurinia Pharmaceuticals Inc.

Withdrawn

Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation (INSPIRE)

Renal Transplantation
Bristol-Myers Squibb

Completed

Belatacept Pharmacokinetic Trial in Renal Transplantation

Renal Transplantation

Argentina, Mexico, United States
The University of Texas Health Science Center,...
Novartis

Withdrawn

Enteric Coated Myfortic for Liver Transplant Recipients

Liver Transplantation

United States
Pfizer

Completed

Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients

Kidney Transplantation

United States, Australia, France, Brazil, Germany, Italy, Canada, Spain, Netherlands, Belgium, Czech Republic, Norway
Astellas Pharma Inc

Completed

A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

Liver Transplantation

United States
Astellas Pharma Inc

Completed

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

Liver Transplantation

United States
Astellas Pharma Korea, Inc.

Completed

A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF (PeACE)

Kidney Transplantation

Korea, Republic of
Pfizer

Completed

A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients

Kidney Transplantation

United States
University Hospital Birmingham NHS Foundation Trust

Completed

Kidney Allograft Recipients in England - an Observational Cohort Study (KARE)

Kidney Transplantation

United Kingdom
Central South University

Unknown

The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

Kidney Transplantation

China
Astellas Pharma Inc

Completed

A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

Renal Transplantation

United States
Novartis Pharmaceuticals

Completed

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

Renal Transplantation
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Novartis Pharmaceuticals

Completed

This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

Renal Transplantation

Switzerland
Hannover Medical School

Completed

Endoscopic Evaluation in Transplantation Candidates

Liver Transplantation

Germany
Novartis Pharmaceuticals

Completed

Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

Renal Transplantation

United States
Hannover Medical School
Corscience, Inc.

Completed

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation (TeleTx)

Lung Transplantation

Germany

3

Subscribe